Sagent Pharmaceuticals recalls Ketorolac injection vials due to potential microbial growth during manufacturing. This could introduce harmful bacteria into the product. Affected vials have specific NDC and lot numbers.
Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.
Take action
Contact the company
📍Recalling firmSagent Pharmaceuticals Inc1901 N Roselle Rd Ste 700 · Schaumburg, IL 60195-3194
“Sagent Ketorolac Injection Recall: Microbial Growth Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38867-sagent-ketorolac-injection-recall-microbial-growth-risk. Based on FDA recall #D-1274-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1274-2019%22&limit=1).
The FDA announced on April 30, 2019, that Sagent Pharmaceuticals Inc voluntarily recalled Ketorolac Tromethamine Injection due to a lack of sterility assurance. The agency stated the recall was initiated after microbial growth was detected during a manufacturing process simulation.
How to tell if you have it
Brand: Sagent Pharmaceuticals
Product: Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials
NDC: 25021-701-02
Lot #: M813513
Expiration: Feb 2020
Units affected: 75,825 vials
The hazard
The recall addresses the potential introduction of microorganisms into the products due to microbial growth detected during a routine simulation of the manufacturing process. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Sagent Pharmaceuticals Inc has issued 10 other recalls since June 7, 2013. Other recent recalls of similar products include Sagent Busulfan Injection (May 4, 2026), Fresenius Kabi Famotidine Injection (Nov. 6, 2025), and Fresenius Kabi Ketamine HCl Injection (Feb. 5, 2026).
How to tell if you have this one
Check for vials labeled 'Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only'. The NDC number is 25021-701-02 and lot number M813513.
Brand
Sagent Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Details
Look for the NDC number 25021-701-02 and lot number M813513 on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1274-2019 (April 30, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1274-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.